lvv-hemorphin-7 has been researched along with oxytocin in 2 studies
| Studies (lvv-hemorphin-7) | Trials (lvv-hemorphin-7) | Recent Studies (post-2010) (lvv-hemorphin-7) | Studies (oxytocin) | Trials (oxytocin) | Recent Studies (post-2010) (oxytocin) |
|---|---|---|---|---|---|
| 59 | 0 | 14 | 21,611 | 1,831 | 5,773 |
| Protein | Taxonomy | lvv-hemorphin-7 (IC50) | oxytocin (IC50) |
|---|---|---|---|
| Oxytocin receptor | Homo sapiens (human) | 0.0027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer, CE; Dwyer, JM; Lin, Q; Ling, HP; Luo, B; Mark, RJ; Neal, S; Platt, BJ; Rosenzweig-Lipson, S; Schechter, LE | 1 |
| Chen, YH; Chen, YJ; Chow, LH; Huang, EY; Kao, JH; Lai, CF; Lin, TY | 1 |
2 other study(ies) available for lvv-hemorphin-7 and oxytocin
| Article | Year |
|---|---|
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
Topics: Amygdala; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Exploratory Behavior; Hemoglobins; Immunoassay; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Ligands; Male; Mice; Microdialysis; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Oxytocin; Time Factors; Up-Regulation | 2010 |
Sex Difference of Angiotensin IV-, LVV-Hemorphin 7-, and Oxytocin-Induced Antiallodynia at the Spinal Level in Mice With Neuropathic Pain.
Topics: Angiotensin II; Animals; Female; Hemoglobins; Hyperalgesia; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Neuralgia; Oxytocin; Pain Management; Peptide Fragments; Sex Characteristics | 2018 |